New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
06:41 EDTAKRXAkorn long-term fundamentals remain unchanged, says Leerink
Leerink says Akron's long-term fundamentals remain unchanged following the company's FY13 guidance call. The firm thinks management met expectations on the top line, provided a reasonable explanation on margins and slightly disappointed on manufacturing capacity expansion. Leerink raised its price target for Akorn shares to $16 from $14-$15 and keeps an Outperform rating on the name.
News For AKRX From The Last 14 Days
Check below for free stories on AKRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 19, 2014
14:18 EDTAKRXAkorn competition settlement over VersaPharm deal approved by FTC
Subscribe for More Information
September 15, 2014
07:10 EDTAKRXAkorn potential KUDCo deal makes strategic sense, says Piper Jaffray
Subscribe for More Information
September 12, 2014
09:00 EDTAKRXNeedham skeptical of potential Akorn deal for Kremers
Subscribe for More Information
September 11, 2014
12:56 EDTAKRXAkorn exploring 'inversion' deal for Belgian drugmaker unit, Reuters says
Subscribe for More Information
12:55 EDTAKRXAkorn pursuing potential inversion deal for UCB unit, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use